Home » Topics » Regulatory

Regulatory
RSS

Novartis seeks approval for lower dose of Estalis in Sweden

Jan. 21, 2003

Caelyx approved in E.U. for metastatic breast cancer

Jan. 16, 2003

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

Approval of Coreg recommended for heart attack patients with impaired cardiac function

Jan. 15, 2003

Infliximab granted priority review by the FDA for fistulizing CD

Jan. 13, 2003

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

Jan. 13, 2003

A potential new indication proposed for losartan

Jan. 10, 2003

Prozac approved for pediatric depression and OCD

Jan. 9, 2003

FDA approves Singulair for seasonal allergic rhinitis

Jan. 9, 2003

FDA approves Clozaril to reduce the risk of suicidal behavior

Jan. 9, 2003